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Abstract
Various investments could help countries deliver on the universal health coverage (UHC) goals set
by the global community; community health is a pillar of many national strategies towards UHC.
Yet despite resource mobilization towards this end, little is known about the potential costs and
value of these investments, as well as how evidence on the same would be used in related deci-
sions. This qualitative study was conducted to understand the use of evidence in policy and financ-
ing decisions for large-scale community health programmes in low- and middle-income countries.
Through key informant interviews with 43 respondents in countries with community health
embedded in national UHC strategies (Ethiopia, Kenya, Malawi, Mozambique) and at global institu-
tions, we investigated evidence use in community health financing and policy decision-making, as
well as evidentiary needs related to community health data for decision-making. We found that evi-
dence use is limited at all levels, in part due to a perceived lack of high-quality, relevant evidence.
This perception stems from two main areas: first, desire for local evidence that reflects the context,
and second, much existing economic evidence does not deal with what decision-makers value
when it comes to community health systems—i.e. coverage and (to a lesser extent) quality.
Beyond the evidence gap, there is limited capacity to assess and use the evidence. Elected officials
also face political challenges to disinvestment as well as structural obstacles to evidence use,
including the outsized influence of donor priorities. Evaluation data must to speak to decision-
maker interests and constraints more directly, alongside financiers of community health providing
explicit guidance and support on the role of evidence use in decision-making, empowering national
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decision-makers. Improved data quality, increased relevance of evidence and capacity for evidence
use can drive improved efficiency of financing and evidence-based policymaking.
Keywords: Economic evaluation, community health, evidence-based policy, health financing, Ethiopia, Kenya, Malawi,
Mozambique
Introduction
Well-resourced close-to-community (CTC) health workers can de-
liver high-quality care; there is extensive, robust, project- and trial-
based evidence for this across a range of settings and disease areas,
as shown in a set of recent reviews of community health pro-
grammes (Chou et al., 2017; Freeman et al., 2017; Jennings et al.,
2017; Perry et al., 2017; Sacks et al., 2017; Schleiff et al., 2017;
Scott et al., 2018). Armed with this evidence, extending access to
primary health care through CTC cadres with an aim of universal
health coverage (UHC) has long been used as an approach and lately
becomes a priority in many countries (Wang et al., 2016; Bhutta,
2017; Javanparast et al., 2018). The World Health Organization has
supported operationalization of extending access in this way
through the development of guidelines for national CTC pro-
grammes (Cometto et al., 2018). Yet in many health systems, com-
munity health remains perceived as an extension of the ‘formal’
system rather than a core, integrated service delivery platform
(Theobald et al., 2015; Schneider and Lehmann, 2016; Tseng et al.,
2019).
Economic evidence should play a predominant role in the inte-
gration of community health into wider health systems, due to the
need for trade-offs between different health investments and compe-
tition for limited resources. There is a small but growing body of
economic evidence on community health programmes, recently pre-
sented in a systematic review by Nkonki et al.; like the evidence on
quality described above, the authors state that most evidence is
‘from small scale and vertical programmes’ (Nkonki, Tugendhaft
and Hofman, 2017). Once community health programmes start
operating at scale, quality of care and performance of CTC pro-
viders do not always live up to their potential (Kok et al., 2015;
Silva et al., 2016; Yourkavitch et al., 2016; Ballard et al., 2017;
Phiri et al., 2017; Lehmann et al., 2019). The limited economic eval-
uations of the quality of large-scale CTC programmes generate un-
certainty about the value of this investment; studies on the costs of
large-scale CTC programmes (Vaughan et al., 2015; Barger et al.,
2017; Daviaud et al., 2017; Nkonki et al., 2017; Taylor et al., 2017)
have rarely incorporated data on the quality of care. In assessing
outcomes, incorporating quality into economic evaluations of CTC
programmes is challenging because of difficulty in defining the
quality of care for CTC interventions and the complex causal path-
ways between CTC quality of care measures and health outcomes.
Poor data quality affects measurement across both costs and out-
comes (Yourkavitch et al., 2016; Regeru et al., 2020).
As an extension or even marginalized aspect of the healthcare
system, community health decision-making does not benefit from
the many formal procedures for generating and using evidence that
have been developed in the wider health sector. For example, there
is a gap in community-focused financing literature; Scott et al.
showed that, out of 122 publications on the ASHA programme in
India between 2005 and 2016, only five dealt with financing (Scott
et al., 2019). Where it exists, community financing literature often
focuses more on community-based micro insurance schemes rather
than macro financing of community health programmes, despite a
predominance of external financing in this space (McCollum et al.,
2018c; Agarwal et al., 2019). Because potential users of evidence
often perceive community-level care as ‘free’ to the system, this lim-
its the commissioning of economic evidence at local and national
levels. Similarly, in the wider sector, the broad literature on proce-
duralism focuses on formalized processes for evidence use, consult-
ation and transparency (Barasa et al., 2015)—yet in community
health as a sub-sector, these processes are not well established. As
such, even when evidence about community health interventions is
available, this evidence may be underutilized in decision-making. In
the absence of sufficient procedures (the largely external), invest-
ment in community health seems to be driven by ideology and global
movements over evidence. A closer look specifically at community
health decisions within the health sector is imperative given the rela-
tive marginalization of community health as an extension of the
health system and its reliance on external financing in many low-
and middle-income countries (LMICs) (Theobald et al., 2015;
Javanparast et al., 2018; Tseng et al., 2019).
This multi-country qualitative study was designed to understand
the role of evidence in how decisions are made for community health
financing and policy at national and global levels. We focus our
study in four countries (Ethiopia, Kenya, Malawi, Mozambique)
that have large-scale public sector community health programmes
that remain highly dependent on external financing. In key inform-
ant interviews with national and global funders, policymakers and
Key Messages
• The use of evidence in national community health policy and financing decisions is limited by its perceived poor quality
and the capacity of decision-makers to use it.
• Most existing evidence is perceived as of limited relevance to domestic decision-making; it is used more by global finan-
ciers of community health.
• Decision-makers emphasize increasing coverage of or access to services community health services—quality is rarely
mentioned as a funding priority.
• Stopping an established approach to community health (disinvesting) in favour of another more economically viable ap-
proach is seen as politically challenging even when evidence exists.
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researchers, we set out to understand what evidence is used and by
whom, and when and what additional evidence could improve the
efficiency of community health decision-making in settings where
CTC providers are an integral part of the health system.
Methods
We used a qualitative cross-sectional approach to understand the
use of economic evaluation evidence in community health priority
setting and financing. Qualitative methods were utilized to allow for
an understanding of the process (how things are currently working),
stakeholders (who is involved) and wider decision space (role of the
health system and context). Given the limited number of individuals
involved in policy and financing decisions and their seniority, key in-
formant interviews were selected as the most appropriate method-
ology to extract relevant information. Data were collected between
November 2017 and November 2018.
Study sites and sampling
Forty three key informant interviews were conducted with purpos-
ively sampled decision-makers involved in community health policy
and financing decisions at national and global levels based on the
sampling frame shown in Table 1. We selected countries with na-
tional community health programmes in Africa that were part of the
REACHOUT consortium: Kenya, Ethiopia, Malawi and
Mozambique1 (REACHOUT, 2013). Respondents included national
and sub-national Ministry of Health staff involved with community
health financing and/or programming and implementers of large-
scale community health programmes. The global interviews
included institutional financiers of community health, community
health researchers and normative agencies. These respondents were
selected to represent those making community health policy and
financing decisions in the selected REACHOUT countries, generat-
ing evidence to inform the decisions, and those affected by the deci-
sions through involvement in translating policy to practice.
Data collection, management and analysis
Interviews were guided by a semi-structured topic guide, which was
piloted in Kenya before use (available in Supplementary File S2). We
asked respondents’ questions about their community health experi-
ence, about domestic and external financing for community health
in their setting, and, using quality improvement as a case example of
a project, about evidence needs, evidence use, and financing mecha-
nisms related to decision-making and the (community health) deci-
sion space.
In all cases except two in Ethiopia and two in Mozambique,
interviews were conducted in English by the corresponding author.
In those four interviews, local researchers with prior experience in
qualitative methods and community health were trained in the inter-
view content and objectives and conducted the interviews.
Thirty nine of 43 total interviews were digitally recorded and
transcribed by local researchers in each country (where they were
conducted in another language, they were transcribed in the local
language and then translated); the remaining respondents asked not
to be recorded and interviewer notes were included in lieu of a tran-
script. Code frame development was done deductively according to
the objectives of the study: understanding decision-maker perspec-
tives on quality and understanding the use of evidence in decision-
making for community health financing and programming.
Additional codes (particularly, detailed information around financ-
ing and economic evidence) were added inductively in the course of
the analysis as they had arisen due to the open questioning style
used in the interviews (Gale et al., 2013) (for full code frame, see
Supplementary File S3). Analysis was assisted by NVivo11 software,
and for each theme, relevant quotes were examined to generate a
draft narrative. A thematic framework approach was used for the
analysis (Gale et al., 2013). Given that there was a single lead re-
searcher conducting interviews and coding, quality assurance was
done in the following ways: (1) review of selected transcripts by se-
nior authors; (2) coding workshop with colleagues where multiple
individuals coded transcripts to ensure inter-coder reliability; and
(3) discussions with and feedback from research partners/co-authors
in each country on emerging themes. For non-recorded interviews,
the notes were included as transcripts and coded in the same way as
verbatim transcriptions described above; direct quotes from these




A total of 43 key informant interviews were conducted with purpos-
ively sampled respondents working in community health at national
Table 1 Sampling framework
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and global levels. In total, these were: global (N¼11), Ethiopia
(N¼10), Kenya (N¼7), Malawi (N¼6) and Mozambique (N¼6);
descriptions of respondents are shown in Table 2. There was a focus
on policy and financing decision-makers, with the latter being over-
represented at global level due to the predominance of external
financing in this area. Implementers and health workers represent
the individuals who translate decisions into practice/action and have
a perception of how and if their evidence gets used in this process.
Of the researchers, who represented a smaller proportion of the total
sample, two were economists and the majority was working more
broadly on implementation research, governance, feasibility and
process evaluations in the CTC space.
Institutions represented at the global level included: UNICEF,
World Health Organization; Global Fund to Fight AIDS,
Tuberculosis and Malaria; Global Financing Facility for Women,
Children and Adolescents; Last Mile Health; Financing Alliance for
Health; United Nations’ Special Envoy for Health; Community
Health Impact Coalition; United States Agency for International
Development; South Africa Medical Research Council; and John
Snow International representing Maternal and Child Health
Integrated Program; out of this group, implementers are those
organizations that deliver community health programmes in coun-
try. Institutions represented at country level are national and sub-
national government staff as well as non-governmental organiza-
tions (NGOs) and International Organisations as relevant to the
community health planning, financing and delivery in each context.
Evidence use in national-level decisions for publicly
funded programmes
The reported use of economic evidence in health policy and financ-
ing decisions varied by country but was generally informal and moti-
vated by individuals instead of systems. Ethiopia demonstrated the
most formalized processes and procedures for the use of economic
evaluation in the health sector at the national level, with a separate
department inside the Federal Ministry of Health’s Planning
Directorate responsible for using and assessing economic evidence
(particularly finance data from National Health Accounts and
evaluation data from Public Health Research Institute). No study
countries systematically required the use of economic evidence in
decision-making for as a formal stage in public policy or financing
decisions for community health. Community health systems were, in
the views of most respondents, an extension of the health system ra-
ther than a core part, evidenced in part by the title of CTC workers
as ‘extension workers’ in some settings. As such, community health
was viewed as a lower priority than other health areas in terms of
commissioning evidence, and related decision-making was less
restricted by formalized processes and requirements for evidence. In
the absence of these governing structures, change was often
described in our data as driven by individual leaders and/or the
desire for political advantage instead of evidence, as in this case
from Kenya:
I haven’t seen anyone talking about an incremental approach [to
policy change in community health]; I have just seen the type like
Kitui [County] where you [leaders] decide today: ‘I’m going to
do this and I’m going to put this money’ (community health re-
searcher, Kenya).
The most commonly available evidence of impact or benefits of
community healthcare investments at national level, understood as
programme performance by the majority of respondents, was gener-
ated by CTC health workers through routine monitoring and evalu-
ation. However, these routine data were not thought by most to be
reliable enough to support decisions; improving the quality of rou-
tine CTC data was considered by several respondents to be a pre-
requisite to its use. This was compounded by the fact that these data
are often paper based (community data are reported in District
Health Information Software 2 only in Kenya and Ethiopia, and
even these are often incomplete), so the process of obtaining per-
formance data from this source may have prohibitive time cost. A
sub-national key informant in Mozambique told us of frustrations
in trying to get and use routine community health programme data
in their work:
The APE [or CHW] is producing data in a useful way but this in-
formation I feel that, I do not know where it is going because I
do not have a report of what happens to ‘my’ information. I get a
bit confused because there is no transparency of where [that] in-
formation goes. When I consult the Ministry, they say that it is
used by the programmes, but we at the level of the province we
do not feel that (policymaker, Mozambique).
Few national-level respondents talked about using cost-effectiveness
evidence to inform decisions, though in Ethiopia there were several
who mentioned aspirations to generate their own cost-effectiveness
data for projects and new programmes. The limited number who
mentioned them stated that cost-effectiveness studies, where avail-
able, are not seen by national policymakers as addressing budget
constraints, as they do not address real constraints on available
financing. This was summarized by a respondent in the Federal
Ministry of Health in Ethiopia as follows:
The results they submitted to us [show] if the implementing se-
cond generation is the extension program cost effective? But it
needs really further discussion and also policy dialogue also with
some stakeholders . . . it’s more expensive . . . I think we need
more data like for example if we implement second generation
extension program all over the country how much cost it will
take and the other thing what are the health gains in this amount
of investment.
In contrast, several respondents discussed costing data being used
alone without effectiveness data. These data were used mainly to
Table 2 Respondent characteristicsa
Level/country Programme policy Programme financing Researcher Implementer/health worker Total
Global 1 5 2 3 11
National/Ethiopia 3 1 1 5 10
National/Kenya 3 1 2 3 8
National/Malawi 2 2 1 3 7
National/Mozambique 2 1 1 4 7
Total 43
aRespondents were allowed in exceptional cases to be included in more than one category or quota.
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fundraise, through approaches like gap analyses, and to decide
whether to expand coverage of the CTC programme.2 Despite
expanding coverage or ‘extension’ of services being a stated aim of
community health programmes in all study countries, no respond-
ents directly stated a need for evidence on the equity of community
health services. Respondents used ‘coverage’ to address primarily
geographical equity considerations, but no direct mention was made
of other aspects of equity. Healthcare workers in Ethiopia described
the equity-linked challenges in their community work:
To work on quality, the problem we face is that patients are
found in geographically difficult areas . . . so that makes problems
to communicate with us.
Among policy makers, there were several mentions of the challenge
of allocating a limited budget across many interventions. Trying to
achieve allocative efficiency is a potential entry for effectiveness evi-
dence to identify the best investments. However, instead of provid-
ing incentives to focus on priority setting, allocation of resources
was linked to coordination between funders and partners to cover
the different aspects of comprehensive but unfunded annual plans.
In this way, coverage sometimes meant avoiding the duplication of
efforts in investments rather than increasing access to healthcare
services. An implementer in Mozambique stated the challenges of
prioritizing investment in community health in their planning proc-
esses simply:
[Access is prioritised over quality] – and this is linked to resour-
ces; if resources are slim and you have to go strengthen at the
community level or the health facility level, what do you do?
Evidence use in funding applications
The influence of external financing and donor priorities on commu-
nity health decisions came out strongly in the data. In the study
countries, external financing is a majority of the community health
financing, yet it was seen as unpredictable and (often) having limited
flexibility. A financing agency key informant in Kenya described the
role of external financing on community health:
. . . the disadvantage of being off budget is you are working out-
side the system. Yeah, it’s a parallel system which is unhelpful in
many ways and complicates things. That’s one of the causes why
community health care is funding ‘off budget’ mainly and by
donor funding.
Each donor and their priorities were described as changeable and
contingent on other fiscal planning and calendars—yet they put
pressure on national government to adapt to and often adopt their
priorities. For many national level key informants, the predomin-
ance of external financing brought about a lack of motivation and/
or space to drive the agenda in their own health sector.
You see like right now say USAID has money and all their money
goes to partners . . . the partners need to implement what USAID
and government have agreed on; so theoretically that is what
happens but we know mostly it is pushed by USAID and we fol-
low that and because the counties just want the money, they will
say: ‘it’s fine let’s go ahead’ . . . (community health researcher,
Kenya).
External financing was seen to limit the value of economic evidence
to government staff; governments are desensitized to the full costs of
these programmes and in some cases view the international priorities
as ‘pre-vetted’ for impact. In addition, these programmes are often
tightly earmarked and thus evidence becomes irrelevant until the
project funding period is over. Externally funded NGO-led projects
are often required to report programmatic costs, but governments
are not directly trading off these investments against other possible
programmes and the focus on sustainability is limited. Instead, the
Ministries of Health are occupied with the coordination of pro-
grammes contingent on external funding cycles rather than driving
implementation based on (local) evidence, as described in
Mozambique:
I see that the Ministry of Health goes with this programme but at
the same time they are not preparing themselves for taking over.
They still rely on the partners; that is the big issue. This pro-
gramme depends too much on the partners (community health
implementer, Mozambique).
Evidence use in priority setting for global financing and
the role of global agendas on domestic financing
Globally, there is a stated or ‘on paper’ agreement about the need
for evidence to underpin decisions, in part to address fairness con-
cerns among those competing for financing. These fairness concerns
were restated in calls by national-level respondents for transparency
in financing decisions by global-level financing mechanisms. Despite
this stated commitment, political processes and prioritization exer-
cises precede the evidence-based decisions in several cases. For ex-
ample, the initial allocation of funds to human immunodeficiency
virus/acquired immune deficiency syndrome, tuberculosis and mal-
aria for each country from the Global Fund is made according to a
formula. Subsequently, community health, as a component of the
health systems strengthening envelope within the country allocation,
has to ‘fight’ for resources from these disease areas. Similarly, in the
Global Financing Facility of the World Bank, the reasons for selec-
tion of the priority countries were opaque, according to this key
informant:
How the 16 countries were selected, I’m not completely sure . . .
well, partly it was our priority countries because there was a pol-
itical economy angle to the countries from the donor side, so
there’s also these countries themselves who say they want . . . to
be part of it so it will require they speak for themselves (key in-
formant, global).
The biggest global items influencing community health, UHC and
the United Nations’ Sustainable Development Goals for health were
mentioned in each of the study countries by at least one respondent
despite there being no direct question about it. Of the respondents
who mentioned it, all national policy makers of funders of commu-
nity health, several did not have a clear definition of UHC, poten-
tially limiting its efficacy at motivating financing or policy shifts.
However, they stated that pressure from global stakeholders to-
wards UHC is increasing, without clarity what evidence would be
needed to measure progress towards this global goal. The perceived
relationship of UHC to economic evidence was limited and primar-
ily related to access to financial protection for community members,
as stated by a policymaker in Kenya:
. . . the Permanent Secretary and the Cabinet Secretary they were
really looking at how community strategy can be used to reach
people in the coverage of the National Hospital Insurance Fund.
The evidence being generated to support these global agendas was
perceived by the majority of respondents to focus predominantly on
feasibility and impact evaluations of small-scale pilots and pro-
grammes in specific locations, sometimes called ‘pilot-itis’. This led
respondents to be concerned that the resulting evidence is not
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relevant to other contexts, even within the same country. In those
sites where CTC providers have greater curative responsibilities,
particularly Ethiopia, respondents felt that a lot of community
health evidence was not relevant to their ‘highly skilled’ CTC pro-
viders, so they tended to call for more ‘local evidence’. Seemingly in
contrast, in Kenya, national policymakers felt that devolution of
decision-making to sub-national administrative units at county level
might have led to the fragmentation of evidence needs, with demand
for research and evaluation from each county.
Quality of care not a priority in the assessment of
investments in community health
Quality of CTC care was usually termed ‘performance’ by respond-
ents, and most respondents had low expectations of quality and per-
formance. By the majority of respondents, CTC care was viewed as
a means of expanding ‘coverage’, focusing largely on geographic
barriers to care (e.g. >5 km to a health facility) rather than social,
economic or other barriers to equitable health care. They viewed
this as reasonable given the relatively simple tasks allocated to most
CTC providers and their limited levels of education and formal
health training. Community health financing decisions, both domes-
tic and external, have similarly emphasized the requirement for geo-
graphic spread over quality, and this was also a focus of responses
that equated coverage with quality, with no mention of ‘effective
coverage’:
We’ve seen that they [the donor] are very much like we want a
number of children immunised to be such and such; it’s not about
quality its really about numbers and coverage (community health
implementer, Ethiopia).
At the national level, decision-makers stated that the aspects of qual-
ity they would like to have evidence of included: improving health
outcomes (in all countries), data quality (mainly Malawi and Kenya,
with two mentions in Mozambique), ownership by and accountabil-
ity of services to citizens (in all study sites except Ethiopia). Most
stated that quality could be improved through better supervision
and policy changes. In Ethiopia, respondents were more likely to
mention health benefits in specific health areas and in some cases to
describe meeting system-wide targets as a proxy for quality (e.g.
quotas for percentages of deliveries attended by a skilled birth at-
tendant). Across countries, evidence for improved quality that
would be acceptable to participants included: changes in reporting
rates for routine data on community health services, increased de-
mand for services at primary healthcare facilities, decreasing burden
of disease and CHW/community satisfaction. However, many
national-level key informants acknowledged that quality was diffi-
cult and expensive to measure, as the challenges with routine data
meant that understanding the quality of care was perceived to re-
quire additional, non-routine data collection. As such, most
respondents also had limited expectations for evaluations to be able
to incorporate robust evidence on quality.
The design and integration of quality management structures in
the Ministries of Health appeared to influence the appetite for eco-
nomic evidence examining quality or performance. In Ethiopia and
Mozambique, quality was a small part of the job description of tech-
nical staff in well-funded disease departments (e.g. malaria). In con-
trast, in both Kenya and Malawi, healthcare quality and standards
were managed by a stand-alone department, supporting dedicated
staff who promoted the quality agenda in evidence and decisions
across the sector. Yet in these countries, quality management staff
were sometimes marginalized or excluded from decision-making
due to a lack to technical health area focus, as shown in this example
from Malawi:
That was our original plan to have quality improvement persons
in each [technical] department; we have one meeting and then
the directorate [of quality management] calling them but of
course nobody showed up and that is the challenge these depart-
ments always have (programme implementer, Malawi).
Yet even where there is an independent quality structure, getting
that structure to consider the ‘extension’ of their mandate to com-
munity level could still prove a challenge, as continuing with the
Malawi example illustrates:
They [the directorate of quality management] . . . initially they
were saying—‘why should we talk about the community?’ and I
said ‘no, then you are joking’ (policymaker, Malawi).
The same was true in Kenya, where the national Kenya Quality
Model for Health had not been functionally extended to the commu-
nity level or even disseminated by the National Department of
Quality and Standards.
Non-evidentiary influences on decisions
At the immediate decision level, almost every discussion came back
to a combination of limited relevant evidence and limited capacity
to use the evidence that exists. This limited capacity was described
as leading to a lack of demand for evidence and limited resources
dedicated to commissioning or generating evidence, creating a vi-
cious cycle. It also creates a vacuum that advocates of particular
approaches or programmes were described as filling with their own
priorities, through power and their political savvy. Decision-makers
try to juggle this influence alongside many other non-evidentiary
limitations:
. . . the decision makers, are they able to use comparative cost
analyses against different programme and make sort of an effect-
iveness decision, sort of that? And I think the answer is no, that
they will only use the data for decision making not in a vacuum,
there’s like a million other constraints . . .. (community health im-
plementer, global).
At the national level, the role of power over evidence appeared to be
related to the degree of decentralization of the health sector, but this
relationship was complex; decentralization was described as allow-
ing space for more levels of ‘politics and power’, while also poten-
tially increasing accountability due to proximity between voters and
decision-makers, so it did not play out the same way in different
locations but was dependent on individuals. Across the countries,
contextual factors including varied responsibilities of community
health workers, limited formal evidence consideration in most an-
nual work planning procedures and complex interactions between
Ministries of Health and of Finance were seen to influence the likeli-
hood of evidence use in decisions. Similarly, a couple global
respondents identified that where programmes were not nationally
led (but rather NGO led), the geographic impacts would be piece-
meal and may not be generalizable across the country.
Finally, interactions (i.e. power) and political viability were key
to understanding decisions—both among global funders ‘competing’
for implementation space in priority countries and among national
policymakers looking for re-election for themselves or their party, as
well as between these global- and national-level actors. This links to
the negative public opinion that faces national and sub-national de-
cision-makers who try to use evidence to justify removing
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established services, or to disinvesting, as this Ethiopian policy-
maker described:
Actually, it is very difficult for communities, for example some
strategies being implemented for the last ten or fifteen years, the
community is highlight dependent on that so there may be a re-
sistance with the community [to stop funding something].
Despite this, global (international and bilateral) influence on nation-
al priorities was consistently present in the data and continues in
large part because it comes with financial support—and expecta-
tions of delivering on donor priorities.
Discussion
This multi-country analysis on the use of evidence in community
health in LMICs highlights a gap around the use of economic evi-
dence in financing and policy decisions. We find limited use of evi-
dence in decision-making for community health and confirm
findings from other studies that power and politics have noteworthy
influence on priority setting. In explaining why evidence is not used,
respondents described a lack of ‘useful evidence’, with available evi-
dence perceived as not generalizable and not responding to the re-
source limitations on the ground, as well as limitations in capacity
to evaluate and apply the evidence meaningfully. Due to a predom-
inance of external financing of CTC programmes, national decision-
makers are desensitized to the full costs of programmes. Donor pri-
orities often fill the vacuum created by ‘useful evidence’ gaps, and
this is reinforced by the unpopularity of disinvestment among con-
stituents. CTC providers continue to be viewed as a means of
increasing access to primary healthcare services; increased coverage
of health services is the main benefits that decision-makers expect
from investment in community health, with quality (or effective
coverage) and equity largely absent from participant-identified evi-
dence gaps.
Evidence use in community health programming is constrained
and influenced by contextual factors unrelated to the relevance and
quality of the evidence. We conceptualize the influences on such
decisions as coming from three levels: micro, meso, and macro as
derived from the results as shown in Figure 1 (Caldwell and Mays,
2012). In the inner circle or micro level, we show the ‘ideal’ of
evidenced-based policy setting and implementation, including prior-
ity setting, evidence assessment, decision-making and financing.
At the meso level, we show the constraints on the ideal micro or
decision level. The first constraint is environmental/epidemiological
and service data availability and quality. At the meso level, routine
community data quality is poor and most countries do not have
Figure 1 Conceptual framework for influences on community health programming decisions.






/heapol/advance-article-abstract/doi/10.1093/heapol/czaa027/5855156 by guest on 12 June 2020
recent sub-national data on epidemiology and costs of interventions.
The second constraint stems from a lack of processes and procedures
(e.g. where annual work planning is done primarily related to histor-
ical expenditure and programming). Marginalization of community
health from the ‘formal’ health system means fewer formalized pro-
cedural requirements for evidence use in decision-making and less
commissioning of such evidence (in comparison with other health
areas). Because of these limitations in community health in many
countries, even where evidence exists, it is perceived as irrelevant
and decision-makers are not encouraged to use it. The third limita-
tion is capacity for evidence selection, understanding and use in
community health decision-makers; this is a finding from consistent
with wider studies in LMIC health systems (Stansfield et al., 2006;
Wickremasinghe et al., 2016; McCollum et al., 2018b,c; Vanyoro
et al., 2019). Comprehensive planning for community health pro-
grammes would involve decision-makers assessing an extensive set
of routine data from health information systems that include: cen-
sus, vital events, monitoring, public health surveillance, resource
tracking, facility-based service statistics and household surveys
(Stansfield et al., 2006). Analysing these data, setting priorities and
then aligning priorities to available resources are essential skills
(Schneider and Nxumalo, 2017), and indeed in a recent study in
Zambia, managers indicated that costing information highlighted
priorities for more efficient use of resources in immunization pro-
gramming (Feldhaus et al., 2019). However, capacity strengthening
around these transferable skills is rarely funded by vertical pro-
grammes, the main source of external financing for community
health programmes (Conn et al., 1996). Increased capacity could in-
crease the appetite for evidence and could be reinforced by involving
policymakers in research activities whenever possible and bringing
them to the ground to see what ‘impact’ and ‘benefits’ means to
workflows in the health system and livelihoods in the wider com-
munities, potentially overcoming political barriers to evidence use,
similar to what Schneider proposes related to community health
governance (Schneider, 2010).
Finally, at the macro level or outer circle, decisions are influ-
enced by health sector structures, decision and fiscal spaces, funders
and their priorities (WHO, 2014; Katahoire et al., 2015a,b;
Greenhalgh et al., 2017; Pfadenhauer et al., 2017; Rajkotia, 2018).
At the macro level, global institutions that finance community
health programmes are more likely to formalize the use of economic
evidence. However, as a result of the levels of external financing,
priorities of global institutions then have an outsize influence on do-
mestic agendas, delinked from local evidence and need in many
cases.
Overall, this builds on the work of McCollum et al. from the
Kenyan context showing that a lack of high-quality, relevant evi-
dence and limited capacity to use it, compounded by external influ-
ences, allows power and politics to trump evidence use in many
community health programming decisions (McCollum et al.,
2018c). We add the generalizability of these findings beyond priority
setting and into non-devolved systems. In this conceptual frame-
work, the different aspects highlighted at each level illustrate where
and how evidence could be leveraged, if available, to overcome the
role of power and politics in decision-making to improve the target-
ing of services and efficiency of the investments in health.
A core tenet of economics is that a decision-maker ought to take
into account both the benefits of the intervention and the resources
required to achieve those benefits and then to compare these relative
to other potential investments and make a rational choice (Varian,
1992). Our findings that respondents do not perceive current cost-
effectiveness studies to reflect their budget constraints suggest that,
at a minimum, available studies do not accurately reflect the oppor-
tunity costs, perhaps due to inappropriate thresholds. Indeed, much
critique of various thresholds (and in some cases, any thresholds at
all) for cost-effectiveness has been levelled in the literature over the
last 10 years (Newall et al., 2014; Marseille et al., 2015; Ochalek
et al., 2015, 2018; Woods et al., 2016). In response to the push for
UHC, the last 5 years have seen the development of a dizzying suite
of investment cases, strategies targeting non-traditional donors and
innovative approaches to promote consistent, sufficient financing of
community health (Singh et al., 2013; Global Financing Facility,
2016; Community Health Financing Compendium, 2017; Fernandes
and Sridhar, 2017; Chou et al., 2018; E&K Consulting, 2018;
Community Health Roadmap, 2019). In most cases, this represents
progress towards integration of community health into broader
health systems, though priorities often continue to reflect donor con-
cerns (likely in response to the fact that community health systems
are still primarily funded by external financing in most countries).
However, it is not clear who is the decision-maker that is intended
to be influenced by many of these cases and studies. Many of them
target that the Ministries of Finance and CTC programme leaders
are rarely explicitly considered, nor are sub-national decision-mak-
ers, despite an increasing emphasis on decentralizing decisions in
LMIC health systems (Bossert and Mitchell, 2011; Otiso et al.,
2017; McCollum et al., 2018a; Abimbola et al., 2019). For this
powerful evidence to be used and useful, it must consider the
decision-maker more explicitly and the constraints on their decision,
e.g. through budget impact analysis rather than simply reporting in-
cremental cost-effectiveness ratios against thresholds (Revill et al.,
2014; Bilinski et al., 2017; Robinson et al., 2017; Ochalek et al.,
2018).
As with any multi-country study and qualitative studies more
generally, there are challenges to generalizability due to the context-
ual variation. However, the results were generally consistent enough
to suggest actions for researchers and to commissioners and users of
economic research evidence in the community health space. The se-
lection of countries from within the REACHOUT consortium near
the end of that programme period might have increased some of the
key informants’ consideration of and awareness of community
health issues as part of the wider healthcare system in comparison to
others in the region. The highly variation in degree of decentraliza-
tion of community health decisions could have also created less con-
vergence around evidence use. In terms of positionality, the
collection of data by a non-local researcher might limit the willing-
ness of some respondents (especially government staff) to be fully
frank and, similarly, conducting interviews in English might have
limited the nuance available to participants with more limited lan-
guage proficiency.
Conclusions
In summary, there is ample room to improve and increase evidence
use in community health programming and financing decisions. The
goals of the health sector are in improving population health and
health outcomes; additional benefits of improved quality of CTC
health worker services are intrinsically valuable but even more com-
plex to measure—aspects such as trust, motivation, inclusion and
adherence. Thus, decision-makers focus on coverage as the priority
benefit that they would like to see represented in evaluations of com-
munity health programmes, yet have limited resources to commis-
sion or undertake evaluations, and limited pressure to use the
results. Politics further constrains decisions primarily in two ways:
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first, hardware investments such as hospitals, vehicles and equip-
ment are easy election ‘wins’, and second, removing established serv-
ices that are less (cost-)effective is politically challenging, even if
evidence exists. If researchers and community health decision-
makers can bridge these gaps between them, the important value of
evidence in improved community health programming and therefore
improved population health will begin to be realized.
However, all potential approaches will have to overcome weak-
nesses in quality of available data, limitations in decision-maker cap-
acity and concerns about applicability of evidence expressed by
respondents in this study.
Notes
1. REACHOUT is a multi-country research consortium focused
on the quality of community health that worked from 2014 to
2019 in six countries (Ethiopia, Kenya, Malawi and
Mozambique in Africa and Bangladesh and Indonesia in Asia).
For this piece of work, we focused on the African countries (for
details on the community health programmes in the four study
countries, see Supplementary File S1).
2. Expanding coverage was used to mean either adding human
resources in existing sites or expanding geography of the
programme.
Supplementary data
Supplementary data are available at Health Policy and Planning online.
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